Now as an option, patients can also be ventilated non-invasively. The Oxylog 2000, a market mainstay for 15 years, will be phased out. The new device joins the Oxylog 1000 and 3000 family in the second quarter of 2008.
The very first Oxylog was introduced to the market 30 years ago. Based on this know-how and expertise, the new Oxylog 2000 plus emergency ventilator, developed by Dräger Medical b.v., subsidiary of Drägerwerk AG & Co. KGaA has responded to customer demand for more advanced ventilation possibilities in emergency care.
With the Oxylog 2000 plus emergency physicians, paramedics and EMTs (Emergency Medical Technicians) can now choose between different ventilation techniques – including the option pressure support (spontaneous breathing support) and non-invasive ventilation. Additionally, the synchronization with the patient’s breathing has been improved resulting in a minimized trigger delay.
The ventilator now has a large display which is divided into three areas. At a glance, users can see the monitored data, airway pressure and ventilation parameters. The airway pressure is displayed in the form of a bar-graph showing current and previous airway pressure measurements, breath by breath.
The Oxylog 2000 plus weighs 5.4 kg, is splash proof, and continues functioning at ambient temperatures of -20°C to +50° C. Drop tests ensure that the Oxylog 2000 plus still functions after a fall from a height of up to 75 cm.
Similar to the Oxylog 1000 and the Oxylog 3000, the Oxylog 2000 plus is built suitable for use in air ambulances and helicopters.
Following the “family-platform approach,” the Oxylog 2000 plus is compatible with the Oxylog 3000 carrying system and accessories.
Drägerwerk AG & Co. KGaA is one of the international leaders in the fields of medical and safety technology: Dräger products protect, support and save human life. Founded in 1889, in 2007 the Group achieved sales of 1,819.5 million Euro worldwide and an EBIT of 151.9 million Euro. Today, Dräger employs around 10,000 people in more than 70 subsidiaries worldwide and has representation in around 190 countries. The Dräger Medical subsidiary offers products, services and integrated system solutions which accompany the patient throughout the care process - Emergency Care, Perioperative Care, Critical Care, Perinatal Care and Home Mechanical Ventilation.
1) The device is not yet available in all countries.Contact for Trade Press:
Birgit Diekmann | Drägerwerk AG & Co. KGaA
Medica 2018: New software for a more efficient planning of minimally invasive surgery
06.11.2018 | Technische Universität Kaiserslautern
SwRI improves structural health monitoring with magnetostrictive transducer
30.10.2018 | Southwest Research Institute
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly
The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...
Scientists developed specially coated nanometer-sized vehicles that can be actively moved through dense tissue like the vitreous of the eye. So far, the transport of nano-vehicles has only been demonstrated in model systems or biological fluids, but not in real tissue. The work was published in the journal Science Advances and constitutes one step further towards nanorobots becoming minimally-invasive tools for precisely delivering medicine to where it is needed.
Researchers of the “Micro, Nano and Molecular Systems” Lab at the Max Planck Institute for Intelligent Systems in Stuttgart, together with an international...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
12.11.2018 | Life Sciences
12.11.2018 | Materials Sciences
12.11.2018 | Physics and Astronomy